Summary of Consolidated Financial Results for the

Third Quarter of Fiscal Year 2022 (Japanese GAAP)

January 31, 2023

Company name:

Nippon Chemiphar Co., Ltd.

Listing: Tokyo Stock Exchange

Securities code:

4539

URL: https://www.chemiphar.co.jp/english/

Representative:

Kazushiro Yamaguchi, President & CEO

Contact:

Shinji Nakajima, Corporate Officer and Senior Manager of Accounts & Finance Department

Phone: 03-3863-1211

Scheduled date of dividend payout:

-

Supplementary documents for quarterly financial results: Yes

Quarterly financial results briefing:

None

*Amounts less than one million yen are rounded down

1. Consolidated Financial Results for the Third Quarter of FY2022 (from April 1, 2022 to December 31, 2022)

(1) Business Results

(Percentages represent year-on-year changes.)

Profit attributable to

Net sales

Operating profit

Ordinary profit

owners of parent

Nine months ended

Million yen

%

Million yen

%

Million yen

%

Million yen

%

December 31, 2022

24,015

(2.9)

192

(82.5)

549

(52.3)

684

(28.1)

December 31, 2021

24,727

-

1,099

-

1,152

-

952

-

(Note) Comprehensive income:

Nine Months ended December 31, 2022: 852 million yen (down 8.7%)

Nine Months ended December 31, 2021: 933 million yen (- %)

Earnings per

Diluted earnings

share

per share

Nine months ended

Yen

Yen

December 31, 2022

189.62

-

December 31, 2021

264.15

-

(Note) The Company has applied the Accounting Standard for Revenue Recognition (ASBJ Statement No. 29, March 31, 2020), etc., effective from the beginning of the fiscal year ended March 31, 2022. The figures for the nine months ended December 31, 2021 are the figures after the application of the relevant accounting standards and percentages for year-on-year changes are not indicated.

(2) Financial Position

Total assets

Net assets

Equity ratio

Net assets per share

As of

Million yen

Million yen

%

Yen

December 31, 2022

50,035

19,171

38.3

5,307.03

March 31, 2022

49,453

18,501

37.4

5,119.99

(Reference) Equity:

As of December 31,

2022: 19,154 million yen

As of March 31, 2022: 18,484 million yen

2. Dividends

Dividend per share

End of fiscal

End of Q1

End of Q2

End of Q3

year

Annual

Year ended

Yen

Yen

Yen

Yen

Yen

-

0.00

-

50.00

50.00

March 31, 2022

Year ending

-

0.00

-

March 31, 2023

Year ending

March 31, 2023 (forecast)

50.00

50.00

(Note) Revision to the forecast for dividends announced most recently: None

3. Forecast of Consolidated Financial Results for the Year Ending March 31, 2023 (from April 1, 2022 to March 31, 2023)

(Percentages represent year-on-year changes.)

Profit attributable to

Net sales

Operating profit

Ordinary profit

owners of parent

Earnings per share

Full-year

Million yen

%

Million yen

%

Million yen

%

Million yen

%

Yen

32,500

(0.0)

300

(63.7)

500

(51.1)

550

(21.5)

152.38

(Note) Revision to the financial results forecast announced most recently: Yes

* Notes

  1. Changes in significant subsidiaries during the period (changes in specific subsidiaries accompanied by a change in the scope of consolidation): No
  2. Accounting methods adopted particularly for the preparation of quarterly consolidated financial statements: No
  3. Changes in accounting policies and changes or restatement of accounting estimates

(i)

Changes in accounting policies accompanying amendments to accounting standards, etc.: No

(ii)

Changes in accounting policies other than (i):

No

(iii) Changes in accounting estimates:

No

(iv) Restatement:

No

  1. Number of shares outstanding (common stock)
    1. Number of shares outstanding at the end of the period (including treasury shares)

As of December 31, 2022:

4,261,420 shares

As of March 31, 2022:

4,261,420 shares

(ii) Number of treasury shares at the end of the period

As of December 31, 2022:

652,241 shares

As of March 31, 2022:

651,170 shares

(iii) Average number of outstanding shares during the period (cumulative from the beginning of the period)

Nine months ended December 31, 2022: 3,609,494 shares

Nine months ended December 31, 2021: 3,605,280 shares

4. Quarterly Consolidated Financial Statements

(1) Quarterly Consolidated Balance Sheets

(Millions of yen)

FY2021

Q3 of FY2022

(As of March 31, 2022)

(As of December 31, 2022)

Assets

Current assets

Cash and deposits

11,645

12,034

-

8,100

7,709

Notes and accounts receivable trade, and contract assets

-

4,544

3,823

Electronically recorded monetary claims operating

Merchandise and finished goods

4,942

6,014

Work in process

1,484

1,482

Raw materials and supplies

2,385

2,829

Income taxes refund receivable

-

169

Others

391

558

Total current assets

33,495

34,621

Non-current assets

Property, plant, and equipment

Buildings and structures, net

4,971

4,981

Machinery, equipment, and vehicles, net

1,931

1,803

Tools, furniture and fixtures, net

319

344

Land

4,345

4,344

Leased assets, net

168

162

Construction in progress

112

221

Total property, plant and equipment

11,848

11,858

Intangible assets

Patent rights

17

13

Trademark rights

61

56

Sales rights

666

454

Leased assets

23

51

Software

105

69

Telephone subscription rights

9

9

Total intangible assets

884

654

Investments and other assets

Investment securities

1,810

1,357

Long-term prepaid expenses

359

462

Retirement benefit assets

309

433

Leasehold and guarantee deposits

68

56

Deferred tax assets

329

236

Others

410

415

Allowance for doubtful accounts

(61)

(61)

Total investments and other assets

3,225

2,901

Total non-current assets

15,957

15,414

Deferred assets

Bond issuance costs

0

0

Total deferred assets

0

0

Total assets

49,453

50,035

- 1 -

(Millions of yen)

FY2021

Q3 of FY2022

(As of March 31, 2022)

(As of December 31, 2022)

Liabilities

Current liabilities

Notes and accounts payable-trade

2,146

2,322

Electronically recorded obligations-operating

7,420

6,613

Short-term borrowings

400

620

Current portion of bonds payable

200

200

Current portion of long-term borrowings

2,581

2,791

Lease obligations

73

77

Accounts payable-other

107

95

Income taxes payable

292

57

Accrued consumption taxes

200

114

Accrued expenses

1,950

1,588

Deposits received

164

267

Refund liabilities

300

243

Others

913

389

Total current liabilities

16,750

15,381

Non-current liabilities

Long-term borrowings

11,399

12,172

Lease obligations

135

156

Provision for retirement benefits for directors

469

451

Net defined benefit liability

132

141

Deferred tax liabilities for land revaluation

915

915

Others

1,149

1,645

Total non-current liabilities

14,202

15,482

Total liabilities

30,952

30,864

Net assets

Shareholders' equity

Capital stock

4,304

4,304

Capital surplus

1,263

1,263

Retained earnings

13,482

13,981

Treasury shares

(3,110)

3,110)

Total shareholders' equity

15,939

16,438

Accumulated other comprehensive income

Valuation difference on available-for-sale securities

547

322

Revaluation reserve for land

2,070

2,072

Foreign currency translation adjustment

(170)

235

Remeasurements of defined benefit plans

98

85

Total accumulated other comprehensive income

2,545

2,715

Share acquisition rights

17

17

Total net assets

18,501

19,171

Total liabilities and net assets

49,453

50,035

- 2 -

  1. Quarterly Consolidated Statements of Income and Comprehensive Income Quarterly Consolidated Statements of Income

(Millions of yen)

For the nine months ended

For the nine months ended

December 31, 2021

December 31, 2022

Net sales

24,727

24,015

Cost of sales

17,642

17,665

Gross profit

7,085

6,349

Selling, general and administrative expenses

5,985

6,156

Operating profit

1,099

192

Non-operating income

Interest income

0

1

Dividend income

27

30

Rental income from non-current assets

4

5

Share of profit of entities accounted for using equity

21

20

method

Foreign exchange gains

155

398

Dividend income of insurance

2

1

Others

16

8

Total non-operating income

226

465

Non-operating expenses

Interest expenses

93

97

Commission expense

5

5

Cost for idle operation

66

-

Others

8

6

Total non-operating expenses

174

108

Ordinary profit

1,152

549

Extraordinary income

Gain on sales of non-current assets

141

10

Gain on sales of investment securities

-

411

Total extraordinary income

141

422

Extraordinary losses

Impairment losses

14

-

Total extraordinary losses

14

-

Profit before income taxes

1,279

971

Income taxes-current

434

124

Income taxes-deferred

(107)

162

Total income taxes

326

286

Profit

952

684

Profit attributable to non-controlling interests

-

-

Profit attributable to owners of parent

952

684

- 3 -

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Nippon Chemiphar Co. Ltd. published this content on 31 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 February 2023 09:41:45 UTC.